---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-25-000043"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2025-09-04T23:59:59+00:00"
generated_at: "2026-05-17T08:24:53.407841+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific EVP/Peripheral Interventions President Mirviss to retire in Dec 2025

## Summary
- Jeffrey B. Mirviss will retire as EVP and President, Peripheral Interventions effective Dec 1, 2025.
- He will stay as senior advisor from Dec 1, 2025 through Feb 27, 2026 at $705,000 prorated salary.
- No successor named; retirement agreement mirrors terms under Executive Retirement Plan and incentive programs.

## SEC filing metadata
- accession: 0000885725-25-000043
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2025-09-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572525000043/0000885725-25-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572525000043/bsx-20250829.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-25-000043
- JSON: https://secwatch.observer/filing/0000885725-25-000043.json
- Plain text: https://secwatch.observer/filing/0000885725-25-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.